Irinotecan hydrochloride trihydrate
Download report
Favorite
Events Timeline
Commercial
Clinical
Drug
Target
Variants
Financial
Trends
Safety
Events Timeline
5D
1M
3M
6M
YTD
1Y
2Y
5Y
Max
Events
FDA approval date
EMA approval date
Patent expiration date
Study first post date
Last update post date
Start date
Primary completion date
Completion date
Results first post date
Mock data
Subscribe for the real data
Subscribe for the real data
Commercial
No data
Clinical
Clinical Trials
663 clinical trials
View more details
Mock data
Subscribe for the real data
Subscribe for the real data
Indications Phases 4
Indication | MeSH | Ontology | ICD-10 | Ph 1 | Ph 2 | Ph 3 | Ph 4 | Other | Total |
|---|---|---|---|---|---|---|---|---|---|
| Colorectal neoplasms | D015179 | — | — | 50 | 153 | 36 | 3 | 8 | 228 |
Indications Phases 3
Indication | MeSH | Ontology | ICD-10 | Ph 1 | Ph 2 | Ph 3 | Ph 4 | Other | Total |
|---|---|---|---|---|---|---|---|---|---|
| Neoplasms | D009369 | — | C80 | 82 | 29 | 5 | — | — | 105 |
| Pancreatic neoplasms | D010190 | EFO_0003860 | C25 | 24 | 35 | 6 | — | 1 | 54 |
| Stomach neoplasms | D013274 | EFO_0003897 | C16 | 14 | 33 | 8 | — | 1 | 53 |
| Esophageal neoplasms | D004938 | — | C15 | 7 | 24 | 3 | — | 1 | 34 |
| Colonic neoplasms | D003110 | — | C18 | 10 | 13 | 5 | — | 1 | 25 |
| Adenocarcinoma | D000230 | — | — | 9 | 17 | 2 | — | 1 | 24 |
| Rectal neoplasms | D012004 | — | — | 7 | 13 | 2 | — | 1 | 20 |
| Neuroblastoma | D009447 | EFO_0000621 | — | 8 | 11 | 1 | — | — | 17 |
| Sarcoma | D012509 | — | — | 6 | 12 | 2 | — | — | 17 |
| Small cell lung carcinoma | D055752 | — | — | 6 | 12 | 2 | — | — | 16 |
Show 22 more
Indications Phases 2
Indication | MeSH | Ontology | ICD-10 | Ph 1 | Ph 2 | Ph 3 | Ph 4 | Other | Total |
|---|---|---|---|---|---|---|---|---|---|
| Lung neoplasms | D008175 | HP_0100526 | C34.90 | 11 | 17 | — | — | — | 28 |
| Central nervous system neoplasms | D016543 | — | — | 13 | 12 | — | — | — | 20 |
| Breast neoplasms | D001943 | EFO_0003869 | C50 | 7 | 12 | — | — | 1 | 19 |
| Non-small-cell lung carcinoma | D002289 | — | — | 7 | 10 | — | — | — | 13 |
| Glioblastoma | D005909 | EFO_0000515 | — | 7 | 7 | — | — | — | 11 |
| Ovarian neoplasms | D010051 | EFO_0003893 | C56 | 6 | 3 | — | — | — | 8 |
| Glioma | D005910 | EFO_0000520 | — | 3 | 4 | — | — | — | 7 |
| Medulloblastoma | D008527 | — | — | 3 | 5 | — | — | — | 6 |
| Astrocytoma | D001254 | EFO_0000271 | — | 5 | 2 | — | — | — | 6 |
| Gliosarcoma | D018316 | — | — | 3 | 4 | — | — | — | 6 |
Show 57 more
Indications Phases 1
Indication | MeSH | Ontology | ICD-10 | Ph 1 | Ph 2 | Ph 3 | Ph 4 | Other | Total |
|---|---|---|---|---|---|---|---|---|---|
| Melanoma | D008545 | — | — | 4 | — | — | — | — | 4 |
| Triple negative breast neoplasms | D064726 | — | — | 3 | — | — | — | — | 3 |
| Precursor cell lymphoblastic leukemia-lymphoma | D054198 | — | C91.0 | 3 | — | — | — | — | 3 |
| Hodgkin disease | D006689 | — | C81 | 3 | — | — | — | — | 3 |
| Burkitt lymphoma | D002051 | — | C83.7 | 2 | — | — | — | — | 2 |
| Anus neoplasms | D001005 | EFO_0003835 | C21 | 2 | — | — | — | — | 2 |
| Ganglioneuroma | D005729 | — | — | 1 | — | — | — | — | 1 |
| Ganglioglioma | D018303 | — | — | 1 | — | — | — | — | 1 |
| Duodenal neoplasms | D004379 | — | — | 1 | — | — | — | — | 1 |
| Nasopharyngeal neoplasms | D009303 | — | — | 1 | — | — | — | — | 1 |
Show 22 more
Indications Without Phase
Indication | MeSH | Ontology | ICD-10 | Ph 1 | Ph 2 | Ph 3 | Ph 4 | Other | Total |
|---|---|---|---|---|---|---|---|---|---|
| Male breast neoplasms | D018567 | — | — | — | — | — | — | 1 | 1 |
Epidemiology
Epidemiological information for investigational and approved indications
View more details
Drug
No data
Target
No data
Variants
No data
Financial
No data
Trends
No data
Safety
Black-box Warning
No Black-box warning
Adverse Events
Top Adverse Reactions
Mock data
Subscribe for the real data
Subscribe for the real data
186 adverse events reported
View more details
© 2020-2023 Collaborative Drug Discovery Inc. (CDD) | Terms of Use